BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37555576)

  • 1. Validation of Moorong Self-Efficacy Scale among Chinese stroke survivors.
    Zhao J; Bai L; Ying Z; Deng Y; He Z; Mou Y; Xu S; Chang K; Chen B; Tang T; Zhao Y
    Disabil Rehabil; 2023 Aug; ():1-5. PubMed ID: 37555576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a translated Chinese version of the Participation Strategies Self-Efficacy Scale: a cross-sectional study.
    Chau JPC; Lo SHS; Zhao J; Choi KC; Lam SKY; Saran R; Shi J; Thompson DR; Lau AYL
    Disabil Rehabil; 2022 Sep; 44(18):5277-5283. PubMed ID: 34061687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural and psychometric property assessment of the Moorong Self-Efficacy Scale in Chinese patients with spinal cord injury.
    Jia M; Chen G; Xie S; Tang J; Wang Y; He X; Liu T; Li K
    Disabil Rehabil; 2022 Sep; 44(19):5631-5637. PubMed ID: 34165003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Moorong Self Efficacy Scale: translation, cultural adaptation, and validation in Italian; cross sectional study, in people with spinal cord injury.
    Marquez MA; Speroni A; Galeoto G; Ruotolo I; Sellitto G; Tofani M; Gonzàlez-Bernal J; Berardi A
    Spinal Cord Ser Cases; 2022 Feb; 8(1):22. PubMed ID: 35173155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. French cross-cultural adaptation and validity of the Moorong Self-Efficacy scale: the MSES-FR, a measure of Self-Efficacy for French people with spinal cord injury.
    Gounelle M; Cousson-Gelie F; Nicolas B; Kerdraon J; Gault D; Tournebise H; Goossens D; Leynaert V; Middleton J; Coffy A; Gelis A
    Disabil Rehabil; 2022 Dec; 44(25):8066-8074. PubMed ID: 34802337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Chinese version of the Participation Strategies Self Efficacy Scale (PS-SES): psychometric evaluation in stroke survivors.
    Wang W; Luo C; Zhang Z; Lee D
    Disabil Rehabil; 2022 Aug; 44(16):4500-4508. PubMed ID: 33818225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation and Validation of a Chinese Version of the Stroke Self-Efficacy Questionnaire in Community-Dwelling Stroke Survivors.
    Lo SH; Chang AM; Chau JP
    Top Stroke Rehabil; 2016 Jun; 23(3):163-9. PubMed ID: 27077974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the Chinese version of the Trunk Impairment Scale in people with a stroke.
    Zhao J; Chau JPC; Zang Y; Choi KC; He R; Zhao Y; Xiang X; Li Q; Thompson DR
    Health Qual Life Outcomes; 2021 Mar; 19(1):85. PubMed ID: 33691738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persian version of the Moorong Self-Efficacy Scale: psychometric study among subjects with physical disability.
    Rajati F; Ghanbari M; Hasandokht T; Hosseini SY; Akbarzadeh R; Ashtarian H
    Disabil Rehabil; 2017 Nov; 39(23):2436-2445. PubMed ID: 27767355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Swedish version of the Moorong Self-Efficacy Scale (s-MSES) - translation process and psychometric properties in a community setting.
    Mangold J; Divanoglou A; Middleton JW; Jörgensen S
    Spinal Cord; 2024 Feb; 62(2):71-78. PubMed ID: 38172426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing equivalence of a Chinese version of the stroke specific quality of life measure for stroke survivors.
    Lo SH; Chang AM; Chau JP
    Disabil Rehabil; 2017 Jun; 39(11):1079-1086. PubMed ID: 27216634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Chinese version of the Measure of Stroke Environment (MOSE): psychometric evaluation in stroke survivors.
    Wang W; Babulal GM; Lin B; Mei Y; Zhang L; Liu Q; Guo Y; Zhang Z
    Disabil Rehabil; 2022 Jun; 44(12):2879-2888. PubMed ID: 33202159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reexamining the Validity and Dimensionality of the Moorong Self-Efficacy Scale: Improving Its Clinical Utility.
    Middleton JW; Tran Y; Lo C; Craig A
    Arch Phys Med Rehabil; 2016 Dec; 97(12):2130-2136. PubMed ID: 27422349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the Chinese version of the Self-Efficacy for Appropriate Medication Use Scale in patients with stroke.
    Dong XF; Liu YJ; Wang AX; Lv PH
    Patient Prefer Adherence; 2016; 10():321-7. PubMed ID: 27042023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring fatigue following stroke: the Chinese version of the Fatigue Assessment Scale.
    Ho LYW; Lai CKY; Ng SSM
    Disabil Rehabil; 2021 Nov; 43(22):3234-3241. PubMed ID: 32142618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychometric properties of Chinese version of SCI Exercise Self-Efficacy Scale in patients with stroke.
    Dong X; Liu Y; Wang A; Wang M
    Patient Prefer Adherence; 2016; 10():1235-41. PubMed ID: 27499614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese Version of the Assessment of Survivor Concerns Scale for Gynecological Cancer Survivors: A Psychometric Study in Taiwan.
    Tsai LY; Wang KL; Tsai JM; Tsay SL
    J Nurs Res; 2019 Oct; 27(5):e41. PubMed ID: 30908430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric properties of the Chinese version of female self-advocacy in cancer survivorship scale.
    Deng M; Lu Z; Wang A; Zhang X; Qiu J; Zhang Y; Chen Y; Wang J
    Asia Pac J Oncol Nurs; 2022 Sep; 9(9):100080. PubMed ID: 36060834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The measurement of self-efficacy in persons with spinal cord injury: psychometric validation of the moorong self-efficacy scale.
    Miller SM
    Disabil Rehabil; 2009; 31(12):988-93. PubMed ID: 19241199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric properties of the Chinese version of the Reproductive Concerns After Cancer Scale (RCAC) for young female cancer survivors.
    Qiao TT; Zheng W; Xing W; Zhang LX; Zhang W; Shi YP; Chen XJ
    Support Care Cancer; 2017 Apr; 25(4):1263-1270. PubMed ID: 27921223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.